Literature DB >> 11422155

Validation of the Chinese translated version of ISAAC core questions for atopic eczema.

H H Chan1, A Pei, C Van Krevel, G W Wong, C K Lai.   

Abstract

BACKGROUND: The International Study of Asthma and Allergies in Childhood (ISAAC) was designed to allow international comparison of epidemiological data on atopic conditions in childhood. In so doing, further aetiological information would be obtained that in turn would provide a framework for future studies. The global ISAAC results on the prevalence of atopic dermatitis indicated a 60-fold variation recorded in different countries. Such a degree of difference may be partially due to the translated questionnaires that were not validated in all of the involved countries.
OBJECTIVE: To validate the Chinese version of the ISAAC core questions for atopic eczema.
METHODS: One thousand nine hundred and twenty children aged between 3 and 5 were randomly recruited from 13 kindergartens in Hong Kong. Using a dermatologist's clinical examination as the gold standard, we validated the Chinese version of the ISAAC core questions for atopic eczema. The Youden's Indexes obtained in our study were compared with those obtained in the United Kingdom's validation study.
RESULTS: The Youden's Indexes obtained in our study were significantly lower than those from the United Kingdom. The low scores were likely to be due to a reduction in the sensitivity of the Chinese questionnaire, which ranged from 23.5% to 70.6%.
CONCLUSION: Our findings indicate that the translated questionnaire is less effective than the English version in assessing the prevalence of atopic eczema. The indication of a low prevalence of atopic eczema among the Chinese population reported in previous studies was at least partially due to problems with the translated questionnaire.

Entities:  

Mesh:

Year:  2001        PMID: 11422155     DOI: 10.1046/j.1365-2222.2001.01089.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  7 in total

1.  Asthma, eczema, and reports on pollen and cat allergy among pupils in Shanxi province, China.

Authors:  D Norbäck; Z-H Zhao; Z-H Wang; G Wieslander; Y-H Mi; Z Zhang
Journal:  Int Arch Occup Environ Health       Date:  2006-07-05       Impact factor: 3.015

2.  Validation of epidemiological tools for eczema diagnosis in Brazilian children: the ISAAC's and UK Working Party's criteria.

Authors:  Agostino Strina; Mauricio L Barreto; Sergio Cunha; Maria de Fátima S P de Oliveira; Shirlei C Moreira; Hywel C Williams; Laura C Rodrigues
Journal:  BMC Dermatol       Date:  2010-11-09

3.  Time-trends for eczema prevalences among children and adults from 1985 to 2015 in China: a systematic review.

Authors:  Wei Liu; Jiao Cai; Chanjuan Sun; Zhijun Zou; Jialing Zhang; Chen Huang
Journal:  BMC Public Health       Date:  2022-07-05       Impact factor: 4.135

4.  The Shanghai Women's Asthma and Allergy Study: objectives, design, and recruitment results.

Authors:  Tina V Hartert; Xinqing Deng; Terryl J Hartman; Wanqing Wen; Gong Yang; Yu-Tang Gao; Meiling Jin; Chunxue Bai; Myron Gross; L Jackson Roberts; James R Sheller; John Christman; William Dupont; Marie Griffin; Xiao Ou Shu
Journal:  Am J Epidemiol       Date:  2008-04-07       Impact factor: 4.897

5.  Prevalence of atopic dermatitis in Korea: analysis by using national statistics.

Authors:  Jung-Seok Yu; Chang-Jong Lee; Ho-Seok Lee; Jihyun Kim; Youngshin Han; Kangmo Ahn; Sang-Il Lee
Journal:  J Korean Med Sci       Date:  2012-05-26       Impact factor: 2.153

6.  Foetal exposure to maternal passive smoking is associated with childhood asthma, allergic rhinitis, and eczema.

Authors:  S L Lee; T H Lam; T H Leung; W H S Wong; M Schooling; G M Leung; Y L Lau
Journal:  ScientificWorldJournal       Date:  2012-08-13

7.  Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study.

Authors:  Qian Chen; Rong Huang; Li Hua; Yifeng Guo; Lisu Huang; Yanjun Zhao; Xia Wang; Jun Zhang
Journal:  Environ Health       Date:  2018-01-17       Impact factor: 5.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.